Ameriprise’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.9M Buy
69,393
+23,847
+52% +$4.93M ﹤0.01% 1669
2025
Q4
$9.41M Sell
45,546
-120
-0.3% -$24K ﹤0.01% 1957
2025
Q3
$8.19M Buy
45,666
+3,448
+8% +$587K ﹤0.01% 2066
2025
Q2
$6.81M Sell
42,218
-408
-1% -$65K ﹤0.01% 2110
2025
Q1
$7.25M Buy
42,626
+3,665
+9% +$637K ﹤0.01% 2013
2024
Q4
$6.49M Buy
38,961
+9,434
+32% +$1.61M ﹤0.01% 2163
2024
Q3
$5.08M Sell
29,527
-797
-3% -$132K ﹤0.01% 2369
2024
Q2
$4.67M Sell
30,324
-1,068
-3% -$160K ﹤0.01% 2366
2024
Q1
$4.84M Sell
31,392
-473
-1% -$72.1K ﹤0.01% 2398
2023
Q4
$5.04M Sell
31,865
-176
-0.5% -$25.3K ﹤0.01% 2344
2023
Q3
$4.69M Sell
32,041
-5,665
-15% -$863K ﹤0.01% 2326
2023
Q2
$5.78M Sell
37,706
-1,609
-4% -$251K ﹤0.01% 2231
2023
Q1
$6.09M Sell
39,315
-5,217
-12% -$819K ﹤0.01% 2182
2022
Q4
$6.86M Buy
44,532
+11,896
+36% +$1.76M ﹤0.01% 2064
2022
Q3
$4.31M Buy
32,636
+1,965
+6% +$276K ﹤0.01% 2326
2022
Q2
$4.16M Buy
30,671
+2,935
+11% +$405K ﹤0.01% 2412
2022
Q1
$4.14M Sell
27,736
-9,164
-25% -$1.36M ﹤0.01% 2548
2021
Q4
$5.98M Sell
36,900
-3,411
-8% -$552K ﹤0.01% 2348
2021
Q3
$6.69M Sell
40,311
-4,089
-9% -$699K ﹤0.01% 2178
2021
Q2
$7.66M Sell
44,400
-4,219
-9% -$697K ﹤0.01% 2133
2021
Q1
$7.88M Sell
48,619
-19,309
-28% -$3.31M ﹤0.01% 2066
2020
Q4
$11.4M Sell
67,928
-6,968
-9% -$1.13M ﹤0.01% 1652
2020
Q3
$11.8M Sell
74,896
-38,084
-34% -$6.23M ﹤0.01% 1439
2020
Q2
$19M Sell
112,980
-16,875
-13% -$2.65M 0.01% 1088
2020
Q1
$17M Sell
129,855
-72,893
-36% -$10.4M 0.01% 1036
2019
Q4
$30.3M Sell
202,748
-11,409
-5% -$1.57M 0.01% 932
2019
Q3
$26.5M Sell
214,157
-58,766
-22% -$7.82M 0.01% 954
2019
Q2
$38.4M Sell
272,923
-9,513
-3% -$1.31M 0.02% 800
2019
Q1
$42.6M Buy
282,436
+88,212
+45% +$12.7M 0.02% 722
2018
Q4
$24.2M Buy
194,224
+2,533
+1% +$346K 0.01% 945
2018
Q3
$30.2M Buy
191,691
+30,649
+19% +$4.64M 0.01% 1024
2018
Q2
$22.5M Buy
161,042
+63,971
+66% +$8.78M 0.01% 1091
2018
Q1
$13.1M Sell
97,071
-1,774
-2% -$242K 0.01% 1443
2017
Q4
$12.3M Buy
98,845
+1,994
+2% +$246K 0.01% 1454
2017
Q3
$12M Buy
96,851
+16,313
+20% +$1.93M 0.01% 1434
2017
Q2
$9.21M Sell
80,538
-2,843
-3% -$306K ﹤0.01% 1623
2017
Q1
$8.99M Sell
83,381
-4,399
-5% -$441K ﹤0.01% 1609
2016
Q4
$7.98M Sell
87,780
-22,453
-20% -$2.1M ﹤0.01% 1686
2016
Q3
$11M Buy
110,233
+23,302
+27% +$2.29M 0.01% 1370
2016
Q2
$7.77M Buy
86,931
+8,470
+11% +$778K ﹤0.01% 1599
2016
Q1
$6.88M Sell
78,461
-65,849
-46% -$5.8M ﹤0.01% 1735
2015
Q4
$16.3M Buy
144,310
+26,653
+23% +$2.87M 0.01% 1065
2015
Q3
$11.9M Sell
117,657
-5,540
-4% -$659K 0.01% 1317
2015
Q2
$15.2M Buy
123,197
+1,010
+0.8% +$122K 0.01% 1222
2015
Q1
$14.5M Buy
122,187
+10,140
+9% +$1.15M 0.01% 1246
2014
Q4
$11.4M Buy
112,047
+13,230
+13% +$1.29M 0.01% 1406
2014
Q3
$9.09M Buy
98,817
+22,189
+29% +$1.92M 0.01% 1548
2014
Q2
$6.32M Buy
76,628
+12,118
+19% +$926K ﹤0.01% 1907
2014
Q1
$4.95M Buy
64,510
+4,372
+7% +$341K ﹤0.01% 2023
2013
Q4
$4.16M Buy
60,138
+7,847
+15% +$515K ﹤0.01% 2110
2013
Q3
$3.39M Buy
52,291
+49,706
+1,923% +$3.14M ﹤0.01% 2180
2013
Q2
$150K Buy
+2,585
New +$148K ﹤0.01% 3208

Other funds holding FBT

Ameriprise's FBT Position: Q1 2026 in Review

Ameriprise increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 52% in Q1 2026, buying an estimated $4.93M and bringing the position to 69,393 shares worth $13.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1669.

Ameriprise first reported a position in FBT in Q2 2013 and has held it in 52 quarters since. The position peaked at $42.6M in Q1 2019. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Ameriprise held 69,393 shares of First Trust NYSE Arca Biotechnology Index Fund worth $13.9M as of Q1 2026.
  • Ameriprise bought 23,847 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $4.93M.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #1669 holding.
  • Ameriprise first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 52 quarters since.
  • Ameriprise's First Trust NYSE Arca Biotechnology Index Fund position peaked at $42.6M in Q1 2019.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.